---
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/264674626.md"
description: "Eli Lilly's U.S. stock pre-market rose nearly 2% at one point, as the company's new weight loss drug achieved over 20% weight reduction and plans to cooperate with the White House to expand Medicare coverage"
datetime: "2025-11-06T13:57:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264674626.md)
  - [en](https://longbridge.com/en/news/264674626.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264674626.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/264674626.md) | [English](https://longbridge.com/en/news/264674626.md)


# 

Eli Lilly's U.S. stock pre-market rose nearly 2% at one point, as the company's new weight loss drug achieved over 20% weight reduction and plans to cooperate with the White House to expand Medicare coverage

### 相關股票

- [Eli Lilly (LLY.US)](https://longbridge.com/zh-HK/quote/LLY.US.md)

## 相關資訊與研究

- [Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | LLY Stock News](https://longbridge.com/zh-HK/news/281171668.md)
- [InSilico Medicine's Loss Widens in 2025; Enters Licensing Agreement With Eli Lilly](https://longbridge.com/zh-HK/news/280951810.md)
- [Eli Lilly Says Long-Term Data Shows Eczema Treatment Provides Up to Four Years of Disease Control](https://longbridge.com/zh-HK/news/280800696.md)
- [Eli Lilly says Taltz and Zepbound met primary and all key secondary endpoints for statistical superiority to Taltz monotherapy at 36 weeks](https://longbridge.com/zh-HK/news/280886666.md)
- [Deals of the day-Mergers and acquisitions](https://longbridge.com/zh-HK/news/281036787.md)